CD44 and lung cancer: First, we found that E2 treatment of A549 cells dramatically decreased p53 expression and increased CD44 expression in lung cancer cells and M2 macrophages, indicating that E2-mediated inhibition of p53 expression may lead to cancer malignancy (Fig. 6A).